AKT1 and cancer: AKT1 is relevant to longevity (Deelen et al., 2013; Nojima et al., 2013), and the dysregulation of AKT signaling leads to diseases for which there are major unmet medical needs, such as cancer, diabetes, and cardiovascular and neurological diseases (Hers et al., 2011).